ESPNIC临床实践指南:急性及危重患儿静脉维持输液治疗——系统评价与荟萃分析
欧洲儿科与新生儿重症监护学会(ESPNIC)多学科专家组采用SIGN分级方法进行系统评价,检索5个数据库至2020年11月,纳入56篇论文,针对急性及危重患儿(胎龄37周至18岁)静脉维持输液治疗的5个问题制定16条推荐。推荐基于异质性证据水平,但专家组共识度高:11/16(69%)达到「强烈共识」,5/16(31%)达到「共识」。关键推荐为使用含葡萄糖的等渗平衡溶液、限制多数住院患儿的静脉维持输液量,并定期监测血浆电解质、血清葡萄糖和液体平衡。
要点
- 多数住院患儿使用含葡萄糖的等渗平衡溶液进行静脉维持输液治疗。
- 限制多数住院患儿的静脉维持输液量。
- 定期监测血浆电解质水平、血清葡萄糖和液体平衡。
- 16条推荐中11/16(69%)达到「强烈共识」,5/16(31%)达到「共识」。
- 系统评价纳入56篇论文,结局报告不一致,推荐基于异质性证据水平。
适用人群与场景
- 急性及危重患儿,年龄从胎龄37周至18岁。
处置流程与药物剂量
- 使用含葡萄糖的等渗平衡溶液进行静脉维持输液治疗。
- 限制多数住院患儿的静脉维持输液量。
- 定期监测血浆电解质水平、血清葡萄糖和液体平衡。
研究设计与关键结果
- ESPNIC多学科专家组采用SIGN分级方法进行系统评价,检索5个数据库至2020年11月,纳入56篇论文,制定16条推荐。
- 推荐基于异质性证据水平,但专家组共识度高:11/16(69%)达到「强烈共识」,5/16(31%)达到「共识」。
- 研究间结局报告不一致。
证据类型、等级与局限
- 证据类型:系统评价与荟萃分析,采用SIGN分级方法进行证据质量与偏倚风险评估。
- 推荐基于异质性证据水平,但专家组共识度高。
- 局限:研究间结局报告不一致。
对床旁实践的改变
- 作者推荐对多数住院急性及危重患儿使用含葡萄糖的等渗平衡溶液进行静脉维持输液。
- 作者推荐限制多数住院患儿的静脉维持输液量。
- 作者推荐定期监测血浆电解质水平、血清葡萄糖和液体平衡。
指南或共识出处
- ESPNIC临床实践指南:急性及危重患儿静脉维持输液治疗——系统评价与荟萃分析,欧洲儿科与新生儿重症监护学会(ESPNIC),发表于Intensive Care Med。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「红旗征与不能漏的情况」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
PURPOSE: Intravenous maintenance fluid therapy (IV-MFT) prescribing in acute and critically ill children is very variable among pediatric health care professionals. In order to provide up to date IV-MFT guidelines, the European Society of Pediatric and Neonatal Intensive Care (ESPNIC) undertook a systematic review to answer the following five main questions about IV-MFT: (i) the indications for use (ii) the role of isotonic fluid (iii) the role of balanced solutions (iv) IV fluid composition (calcium, magnesium, potassium, glucose and micronutrients) and v) and the optimal amount of fluid.
METHODS: A multidisciplinary expert group within ESPNIC conducted this systematic review using the Scottish Intercollegiate Guidelines Network (SIGN) grading method. Five databases were searched for studies that answered these questions, in acute and critically children (from 37 weeks gestational age to 18 years), published until November 2020. The quality of evidence and risk of bias were assessed, and meta-analyses were undertaken when appropriate. A series of recommendations was derived and voted on by the expert group to achieve consensus through two voting rounds.
RESULTS: 56 papers met the inclusion criteria, and 16 recommendations were produced. Outcome reporting was inconsistent among studies. Recommendations generated were based on a heterogeneous level of evidence, but consensus within the expert group was high. "Strong consensus" was reached for 11/16 (69%) and "consensus" for 5/16 (31%) of the recommendations.
CONCLUSIONS: Key recommendations are to use isotonic balanced solutions providing glucose to restrict IV-MFT infusion volumes in most hospitalized children and to regularly monitor plasma electrolyte levels, serum glucose and fluid balance.
参考来源
- Brossier DW, Tume LN, Briant AR, et al. ESPNIC clinical practice guidelines: intravenous maintenance fluid therapy in acute and critically ill children- a systematic review and meta-analysis. Intensive Care Med. 2022. PMID: 36289081. doi:10.1007/s00134-022-06882-z
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。